To characterize the activation of cytotoxic CD4+ and CD8+ T cells, the main cellular mediators of the anti-tumor immunity, we first assayed the expression of the immune checkpoints PD-1, LAG-3, and TIM-3, known to reflect the immune status of TILs in solid tumors [21]. This evidence concerns the gene CD8A and neoplasm.